-
1 Comment
Sunflower Pharmaceutical Group Co.,Ltd is currently in a long term uptrend where the price is trading 10.3% above its 200 day moving average.
From a valuation standpoint, the stock is 76.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.3.
Sunflower Pharmaceutical Group Co.,Ltd's total revenue sank by 20.7% to $606M since the same quarter in the previous year.
Its net income has increased by 17.5% to $80M since the same quarter in the previous year.
Finally, its free cash flow grew by 214.4% to $100M since the same quarter in the previous year.
Based on the above factors, Sunflower Pharmaceutical Group Co.,Ltd gets an overall score of 4/5.
| Exchange | SHE |
|---|---|
| CurrencyCode | CNY |
| ISIN | CNE100001WT7 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Beta | 0.32 |
|---|---|
| Market Cap | 9B |
| PE Ratio | 10.99 |
| Target Price | 23.28 |
| Dividend Yield | 9.0% |
Sunflower Pharmaceutical Group Co.,Ltd engages in the research and development, manufacturing, and marketing of Chinese patent medicines in China and internationally. The company produces chemical and biological medicines, and health care products. It also provides products covering various therapeutic areas, including pediatrics, gynecology, digestive system, respiratory and cold, rheumatic bone disease, and cardiovascular and cerebrovascular; supplements; and antibiotics and children's medicinal products. The company sells its products under the Sunflower and Little Sunflower brands. Sunflower Pharmaceutical Group Co.,Ltd was founded in 2005 and is headquartered in Harbin, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 002737.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
